Joseph Oliveto - 02 Feb 2026 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Reporting relationship: President and CEO, Director
Issuer ticker: MIST
Reported as of: 02 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Feb 2026, 17:50:04 UTC
Prior SEC filing: 09 Jan 2026
Next SEC filing: 20 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Oliveto

Key filing fact

Joseph Oliveto filed Form 4 for Milestone Pharmaceuticals Inc. (MIST) on 04 Feb 2026.

Key facts

This page summarizes Joseph Oliveto's Form 4 filing for Milestone Pharmaceuticals Inc. (MIST).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Feb 2026, 17:50.

Change

Previous filing in this sequence was filed on 09 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001437782 Primary reporting owner

Oliveto Joseph

Relationship: President and CEO, Director
Address: C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, QUEBEC, CANADA
Signature: /s/ Joseph Oliveto
Signature date: 04 Feb 2026

This filing has been restated. Open the amended filing.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIST transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +679,000
Change %
Price: $0.000000
Shares after: 679,000
Date: 02 Feb 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 679,000
Exercise price: $1.97
Footnotes: F1

MIST transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +453,000
Change %
Price: $0.000000
Shares after: 453,000
Date: 02 Feb 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 453,000
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Footnote F2

Each restricted stock unit represents a contingent right to receive one common share.

Footnote F3

One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date.